Skip to main content
logo
DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
6.68
+0.13 (2.06%)
Aug 5, 2026, 3:17 PM EDT - Market open

DiaMedica Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
3604282331084299
Market Cap Growth
103.55%83.99%115.68%158.02%-57.64%-48.11%
Enterprise Value
308.55368.14188.755.318.7553.57
Last Close Price
6.687.965.432.841.583.73

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
7.467.625.712.111.312.24
P/TBV Ratio
7.026.675.391.811.311.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.010.010.010.00
Net Debt / Equity Ratio
-1.08-1.06-1.08-1.03-1.04-1.02
Net Debt / EBITDA Ratio
6.421.741.642.472.363.31
Net Debt / FCF Ratio
1.652.051.982.802.853.67
Quick Ratio
8.9811.728.2319.1215.4929.69
Current Ratio
9.1111.818.2819.2715.6129.82
Return on Equity (ROE)
-67.93%-67.68%-53.27%-46.77%-36.06%-38.81%
Return on Assets (ROA)
-14.00%-63.92%-53.16%-48.14%-35.10%-37.13%
Return on Capital Employed (ROCE)
-15.46%-70.78%-57.80%-50.88%-36.72%-38.94%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-19.44%-16.28%-24.07%-23.16%-27.29%-32.48%
Total Shareholder Return
-19.44%-16.28%-24.07%-23.16%-27.29%-32.48%
SEC Filings: 10-K · 10-Q